Pharmacology PhD

The Department of Molecular and Clinical Pharmacology provides excellent opportunities for basic and clinical research on drug safety science, immuno-pharmacology, individualized medicines, nanomedicines and HIV.

Overview

The department is among the most highly rated for research in the United Kingdom and hosts the MRC funded Centre for Drug Safety Science and the Wolfson Centre for Personalized Medicine.

We have state-of-the-art research facilities and funding from sources including MRC, BBSRC, Wellcome Trust, NIHR, Wolfson Foundation and the EU.

Our focus is on research that is directed towards understanding disease processes, defining therapeutic strategies for intervention, and the scientific basis of drug safety. The ultimate aim of this research is to translate laboratory findings into the clinic for the benefit of patients, the public and the healthcare system.

Our research specifically focuses on the following areas:

Drug Safety Science - We undertake fundamental clinical and basic research into the causes, characteristics and consequences of adverse drug reactions to improve the benefit-risk ratio of current and new medicines

Personalized Medicine – We aim to identify the specific differences which cause individuals to respond to drugs differently

Immuno-pharmacology - We undertake basic and clinical research to characterize drug interactions with immune cells and identify novel drug targets

Applicants for postgraduate research study at Liverpool are normally expected to hold a UK first degree with a First Class or Upper Second Class degree classification, or a Second Class degree plus a Master’s degree. Equivalent international qualifications are also accepted, and their equivalence will be evaluated on the basis of the information provided by the National Academic Recognition and Information Centre (NARIC) as well as internal guidance based on our experience of a qualification’s suitability as a preparation for our programmes.